SMAD3 and neoplasm: Subsequently, MMA has also been confirmed in vivo to increase the expression of INHBA, Ki-67, p-Smad2, p-Smad3, and EMT markers, according to immunohistochemistry, immunofluorescence, and western blotting assays of subcutaneous tumor tissues.